Other News

RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders

Initial Revenues Expected this Quarter, and Customer Pipeline for RenovoCath Standalone Device Continues to Expand, Including High Volume National Cancer Institute-Designated Centers RenovoCath Gaining Validation in an Initial U.S. Market Estimated at $400 Million Annually MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company […]

St. Joseph’s Children’s Hospital First in Southeast United States to Implant First-of-Its-Kind Cardiac Stent for Infants

TAMPA, Fla., Feb. 26, 2025 /PRNewswire/ — The Patel Children’s Heart Institute at St. Joseph’s Children’s Hospital is the first in the southeastern United States and one of only a handful of programs in the world to implant a new stent specifically created to enlarge narrowed blood…

Jupiter Endovascular Appoints Fred Ong as Chief Financial Officer

MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup transforming endovascular medicine with a new class of interventions, announced today that experienced medtech finance and operations executive Fred Ong has joined the company as Chief Financial Officer. “Fred is joining us at a pivotal time as we build upon […]

HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock

February 25, 2025 04:01 PM Eastern Standard Time SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the underwriter of its previously announced public offering of HeartBeam’s common stock has exercised its option to purchase an […]

Bracco and Zereau Join Forces for Innovative Research Program Aimed at Improving Sustainability in Medical Imaging

26th FEBRUARY 2025, Milan – Bracco Imaging SpA, a world leader in diagnostic imaging and Zereau BV, a provider of unique water technology for the healthcare sector, announced today they have signed an agreement to launch the second stage of a groundbreaking research program aimed at improving the sustainability of […]

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced that it will release its fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.